Japanese pharma giant Eisai and Swiss pharma biggie Novartis Pharma AG have dragged Hyderabad-based Aurobindo Pharma to a US court alleging patent infringement of their anti-epilepsy drug Banzel.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/RhYVDa7
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Hyderabad's Aurobindo Pharma faces case in US over epilepsy drug
https://ift.tt/j09VyhR
No comments:
Post a Comment